V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270013124 | 270008663 | 1.87 | 92.3 | null | 2015-05-06 | 2015-07-26 | Escalated BEACOPP | 2 | N | 270013865 | BEACOPP |
| 270013125 | 270008663 | null | 116.7 | Palliative (P) | 2013-04-28 | 2013-07-11 | Cetuximab 14 day | N | null | 270013865 | CETUXIMAB |
| 270013126 | 270008665 | 1.62 | 44.1 | null | null | 2017-02-22 | BEACOPP-14 | N | N | 270013884 | BEACOPP |
| 270013127 | 270008666 | 1.88 | 79.8 | Curative (C) | 2014-04-11 | 2014-04-11 | COPP + Dacarbazine | 2 | N | 270013890 | COPP + DACARBAZINE |
| 270013128 | 270008667 | 1.55 | 45.1 | Curative (C) | 2016-12-03 | 2017-02-10 | CETUXIMAB | 02 | N | 270013894 | CETUXIMAB |
| 270013129 | 270014093 | 1.74 | 59.6 | Palliative (P) | 2017-08-10 | 2018-02-06 | CETUXIMAB | 2 | N | 270013902 | CETUXIMAB |
| 270013130 | 270008668 | null | 56.2 | Palliative (P) | 2017-01-21 | 2017-03-30 | CETUXIMAB | null | null | 270013911 | CETUXIMAB |
| 270013131 | 270008669 | 1.79 | 102.4 | Unknown (U) | 2018-01-09 | 2018-01-18 | Escalated BEACOPP | N | null | 270013925 | BEACOPP |
| 270013132 | 270008670 | null | null | Curative (C) | 2015-07-03 | 2015-08-05 | HD EuroNet-PHL-C1 COPDAC | 01 | null | 270013928 | TRIAL |
| 270013133 | 270008671 | 1.77 | 53.1 | Curative (C) | 2014-05-04 | 2015-03-31 | CETUXIMAB | N | N | 270013928 | CETUXIMAB |
| 270013134 | 270008672 | 0 | 58.4 | Curative (C) | 2014-07-14 | 2014-09-09 | HD EuroNet-PHL-C1 COPDAC | Y | N | 270013934 | TRIAL |
| 270013135 | 270008672 | 1.85 | 61.1 | Curative (C) | 2017-03-20 | 2017-03-24 | Trial Unspecified | N | N | 270013934 | TRIAL |
| 270013136 | 270019119 | null | 134.35 | Curative (C) | 2014-10-17 | 2014-10-17 | CETUXIMAB | 02 | N | 270013943 | CETUXIMAB |
| 270013137 | 270019897 | 0 | 80.5 | Curative (C) | 2018-02-07 | 2018-02-10 | COPP + Dacarbazine | N | N | 270013944 | COPP + DACARBAZINE |
| 270013138 | 270019897 | null | 43.1 | Curative (C) | 2017-11-19 | 2017-11-19 | HD EuroNet-PHL-C1 COPDAC | N | N | 270013944 | TRIAL |
| 270013139 | 270019897 | 1.69 | 39.2 | Curative (C) | null | 2018-02-09 | Cetuximab 14 day | 02 | N | 270013944 | CETUXIMAB |
| 270013140 | 270008673 | 1.59 | 50 | Curative (C) | 2016-06-03 | 2016-06-06 | Cetuximab 14 day | null | N | 270013962 | CETUXIMAB |
| 270013141 | 270008674 | 0 | 51.8 | Curative (C) | 2017-06-06 | 2017-06-06 | COPP + Dacarbazine | N | N | 270013967 | COPP + DACARBAZINE |
| 270013142 | 270008675 | 1.83 | 45.1 | Palliative (P) | 2012-08-22 | 2014-03-28 | Cetuximab 7 day (>Cycle 2) | N | N | 270013967 | CETUXIMAB |
| 270013143 | 270008676 | 1.85 | 89.2 | Curative (C) | 2017-09-20 | 2017-09-27 | Cetuximab 7 day (>Cycle 2) | N | N | 270013969 | CETUXIMAB |
| 270013144 | 270008679 | 1.89 | 63 | Curative (C) | 2016-11-10 | 2016-11-22 | HD EuroNet-PHL-C1 COPDAC | null | null | 270013969 | TRIAL |
| 270013145 | 270008679 | null | 92 | Curative (C) | 2013-12-21 | 2014-02-22 | COPP + Dacarbazine | N | N | 270013969 | COPP + DACARBAZINE |
| 270013146 | 270008682 | 1.72 | 55.7 | Curative (C) | 2013-07-08 | 2013-07-10 | COPP + Dacarbazine | 02 | N | 270013978 | COPP + DACARBAZINE |
| 270013147 | 270008684 | 1.68 | 85 | Neo-adjuvant (N) | 2016-11-03 | 2016-11-03 | COPP + Dacarbazine | 02 | N | 270013981 | COPP + DACARBAZINE |
| 270013148 | 270008684 | 0 | 59.6 | Curative (C) | 2014-04-28 | 2014-06-30 | COPP + Dacarbazine | N | N | 270013981 | COPP + DACARBAZINE |
| 270013149 | 270019612 | 1.8 | 80 | Curative (C) | 2014-01-30 | 2014-03-02 | CETUXIMAB | null | null | 270013989 | CETUXIMAB |
| 270013151 | 270008686 | 1.79 | 79.8 | Curative (C) | 2016-03-04 | 2016-03-07 | Trial Unspecified | N | N | 270013991 | TRIAL |
| 270013152 | 270008689 | 1.73 | 66.8 | Neo-adjuvant (N) | 2016-10-09 | 2017-06-04 | CETUXIMAB | N | Y | 270013992 | CETUXIMAB |
| 270013153 | 270008690 | null | 111 | Curative (C) | 2016-08-22 | 2016-10-29 | Escalated BEACOPP | N | null | 270013996 | BEACOPP |
| 270013154 | 270008691 | 1.71 | 53.1 | Palliative (P) | 2017-02-23 | 2017-02-24 | Trial Unspecified | 01 | N | 270013997 | TRIAL |
| 270013155 | 270008692 | 1.51 | null | Curative (C) | 2017-08-14 | 2017-10-16 | Trial Unspecified | 02 | N | 270013997 | TRIAL |
| 270013156 | 270008693 | 1.64 | 89 | null | 2018-01-25 | 2018-02-01 | BEACOPP-14 | 2 | N | 270014006 | BEACOPP |
| 270013157 | 270008694 | 1.78 | 73 | Curative (C) | 2016-10-24 | 2016-10-25 | BEACOPP-14 | N | N | 270014006 | BEACOPP |
| 270013158 | 270008695 | 0 | 39.2 | Curative (C) | 2015-12-21 | 2016-05-03 | HD EuroNet-PHL-C1 COPDAC | N | N | 270014015 | TRIAL |
| 270013159 | 270008696 | null | 58.5 | Curative (C) | 2014-06-05 | 2014-08-14 | Cetuximab 7 day (Cycle 1) | N | N | 270014019 | CETUXIMAB |
| 270013160 | 270008697 | null | 73.9 | Curative (C) | 2016-07-10 | 2016-07-10 | COPP + Dacarbazine | N | N | 270014019 | COPP + DACARBAZINE |
| 270013161 | 270008699 | 1.52 | 80.4 | Curative (C) | 2014-06-02 | 2014-06-15 | Escalated BEACOPP | N | N | 270014039 | BEACOPP |
| 270013162 | 270008699 | 1.78 | 37.1 | Palliative (P) | 2014-10-16 | 2014-10-16 | CETUXIMAB | null | null | 270014039 | CETUXIMAB |
| 270013163 | 270008700 | 1.6 | 59.2 | Curative (C) | 2015-10-13 | 2015-10-13 | Escalated BEACOPP | 02 | N | 270014046 | BEACOPP |
| 270013164 | 270008701 | 1.85 | 66.5 | null | 2017-08-10 | 2017-08-15 | BEACOPP | null | Y | 270014059 | BEACOPP |
| 270013165 | 270014109 | 0 | 73.6 | Disease modification (D) | 2017-08-05 | 2017-08-13 | HD EuroNet-PHL-C1 COPDAC | 01 | N | 270014061 | TRIAL |
| 270013166 | 270014109 | null | 50.9 | Curative (C) | 2015-12-18 | 2015-12-31 | Escalated BEACOPP | N | null | 270014061 | BEACOPP |
| 270013167 | 270014109 | null | 97 | Neo-adjuvant (N) | 2014-11-17 | 2014-11-21 | COPP + Dacarbazine | N | N | 270014061 | COPP + DACARBAZINE |
| 270013168 | 270008702 | 1.65 | null | Curative (C) | 2016-11-09 | 2016-11-17 | CETUXIMAB | 02 | N | 270014075 | CETUXIMAB |
| 270013169 | 270008703 | null | 70 | Curative (C) | 2015-02-27 | 2015-12-13 | CETUXIMAB | 2 | N | 270014081 | CETUXIMAB |
| 270013170 | 270008704 | 0 | 42 | Neo-adjuvant (N) | 2015-04-17 | 2015-06-20 | COPP + Dacarbazine | N | N | 270014084 | COPP + DACARBAZINE |
| 270013171 | 270016731 | 1.76 | 67.9 | Disease modification (D) | null | 2014-11-02 | Trial Unspecified | null | N | 270014093 | TRIAL |
| 270013172 | 270016731 | 1.76 | null | null | 2013-11-24 | 2013-11-24 | BEACOPP-14 | 02 | Y | 270014093 | BEACOPP |
| 270013173 | 270016731 | 0 | 102 | Curative (C) | 2014-06-19 | 2014-08-16 | HD EuroNet-PHL-C1 COPDAC | Y | N | 270014093 | TRIAL |
| 270013174 | 270014111 | 1.54 | 74.8 | Curative (C) | 2015-05-12 | 2015-05-19 | Escalated BEACOPP | N | N | 270014097 | BEACOPP |